Pero Hrabač

Pero Hrabač

Auto-generated profile, based on publicly available information

Pero Hrabač

Department of Medical Statistics, Epidemiology and Medical Informatics, School of Medicine, University of Zagreb, Zagreb, Croatia

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 April 2017 in Foot & Ankle International
Verified
Journal Article
Open access
DDDamjan Dimnjaković
Damjan Dimnjaković
PHPero Hrabač
Pero Hrabač
IBIvan Bojanić
Ivan Bojanić
Background: A tourniquet is usually used during anterior ankle arthroscopy to allow for improved visibility and reduced operation time. However, this has not been demonstrated to be true in clinical studies on knee arthroscopy, while limited tourniquet time has been described as a possible factor to lower the complication rate of ankle arthroscopy. The purpose of this randomized controlled trial was to examine the effect of tourniquet use on arthroscopic visualization, operative time, postoperative intra-articular bleeding, postoperative pain scores, and outcome of anterior ankle arthroscopy. Methods: A consecutive series of 50 patients who were scheduled for anterior ankle arthroscopy were randomized to have the surgery done either without the tourniquet inflated (25 patients) or with the tourniquet inflated (25 patients). The patients were evaluated by the course of the surgery, postoperative intra-articular bleeding, and pain during the early postoperative period, and subjective and objective functional scores were used to evaluate the condition of the ankle before and 3 and 6 months after the surgery. Forty-nine patients were present at the final follow-up, 6 months after the surgery. Results: The results between the groups were comparable regarding the duration of the operative procedure, consumption of sterile saline, visualization, and functional scores. A notable difference between the groups in favor of the nontourniquet group was present regarding postoperative bleeding but was not statistically significant. A statistically significant difference in favor of the nontourniquet group was found regarding postoperative pain during several days in the early postoperative period. Conclusion: Our study showed that anterior ankle arthroscopy was performed adequately without the use of a tourniquet and that it had the same operative course as cases in which the tourniquet was used and functional outcomes that were not worse than cases in which the tourniquet was used. Level of Evidence: Level I, prospective randomized controlled trial

26 February 2025 in European Journal of General Practice
Verified
Journal Article
Open access
GPGoranka Petriček
Goranka Petriček
ZKZalika Klemenc-Ketiš
Zalika Klemenc-Ketiš
ZAZlata Ožvačić Adžić
Zlata Ožvačić Adžić
VCVenija Cerovečki
Venija Cerovečki
SWSara Judith Willems
Sara Judith Willems
DPDavorina Petek
Davorina Petek
Person-centred care (PCC) is a fundamental principle in general practice, emphasising practices tailored to individual patient preferences, needs, and values. Despite the importance of PCC, general practitioners (GPs) face obstacles in effectively implementing it, with associated factors remaining unclear. The PACE GP/FP study aims to explore GPs' attitudes towards PCC and the factors facilitating or hindering its implementation in daily practice across European countries. This paper outlines the PACE GP/FP study protocol. The cross-sectional design with data collection via an online survey distribution to GPs in 24 European countries. Study instruments include two validated questionnaires (Perceived Stress Scale (PSS) and Patient Physician Orientation Scale (PPOS)) and additional items covering general information about the doctor and their practice, as well as facilitators and barriers to PCC. These additional items were specifically developed for the study, translated using the forward-backward method, evaluated through cognitive debriefing, and integrated into the REDCap platform to create language and country-specific survey links. The STROBE checklist guides the reporting of the manuscript. The PACE GP/FP study will provide a comprehensive exploration of GPs' attitudes towards PCC and the factors shaping its practice in Europe. The findings from the PACE GP/FP study will provide evidence for designing future implementation strategies and guide targeted interventions to promote PCC in primary care across Europe.

16 April 2025 in Reviews in Cardiovascular Medicine
Verified
Journal Article
Open access
PDF file
MPMislav Puljevic
Mislav Puljevic
ECEugen Ciglenecki
Eugen Ciglenecki
VPVedran Pašara
Vedran Pašara
IPIvan Prepolec
Ivan Prepolec
MDMia Dubravcic Dosen
Mia Dubravcic Dosen
VVVedran Velagic
Vedran Velagic
Background: Implantable cardioverter defibrillators (ICDs) have significantly reduced the incidence of sudden cardiac death in patients with heart failure, particularly those with ischemic heart disease. However, the impact on overall mortality remains controversial, especially in non-ischemic heart failure patients. The Danish Study to Assess the Efficacy of ICDs in Patients with Non-Ischemic Systolic Heart Failure (DANISH) trial and subsequent studies have questioned the efficacy of ICDs in this population, particularly among older patients. The present study aimed to evaluate survival outcomes and predictors in a Croatian cohort of patients with an ICD or cardiac resynchronization therapy defibrillator (CRT-D) device. Methods: This retrospective cohort study analyzed data from 614 patients who received an ICD or CRT-D device at KBC Zagreb between 2009 and 2018. Patient data, including demographic information, device indication, and clinical parameters, were collected at the time of implantation. Follow-up data were systematically recorded to assess device activation and survival outcomes. Statistical analyses included a detailed descriptive analysis, Kaplan–Meier survival estimates, and Cox regression models. Results: The cohort consisted predominantly of males (83.4%), with a mean age of 58.7 years. Most had reduced left ventricular ejection fraction (mean 31.4%) and were classified as New York Heart Association (NYHA) class II or III. Over a median follow-up of 48.4 months, 36.6% of patients died. Device activation occurred in 30.3% of patients, with appropriate activation observed in 88.2% of these cases. Cox regression identified age, non-sustained ventricular tachycardia (NSVT), and decompensation history as significant survival predictors. Conclusions: This study confirmed that appropriate device activation improved survival in patients with an ICD/CRT-D. Age, NSVT, and history of decompensation were key predictors of device activation and survival outcomes. These findings underscore the need for individualized patient assessment when considering inserting ICDs, particularly in non-ischemic heart failure patients. Further research is needed to refine clinical guidelines and optimize patient selection for ICD therapy.


11 April 2019 in Hernia
Verified
Journal Article
Closed access
PDF file
JFJ. Filipović-Čugura
J. Filipović-Čugura
ZMZ. Misir
Z. Misir
PHP. Hrabač
P. Hrabač
TOT. Orešić
T. Orešić
DVD. Vidović
D. Vidović
AMA. Mijić
A. Mijić

11 October 2021
Verified
Conference Paper
Open access
PDF file
LILana Ivković
Lana Ivković
IHIva Hojsak
Iva Hojsak
IMIvana Trivic Mazuranic
Ivana Trivic Mazuranic
SSSara Sila
Sara Sila
PHPero Hrabač
Pero Hrabač
SKSanja Kolacek
Sanja Kolacek
Primary aims of this study were to determine the annual incidence and geographic distribution of pediatric inflammatory bowel disease (IBD), respectively existence of north to south gradient in Croatia as well as baseline characteristics at the time of diagnosis. Secondary aim was to compare data on frequency and distribution of pediatric IBD in two consecutive years. This is a prospective, cohort, multicenter observational study based on the data obtained from the newly established Croatian national registry for children with inflammatory bowel disease. Children and adolescents younger than 18 years diagnosed with IBD, according to revised Porto criteria, in time period between June 1st, 2016 and May 31st, 2017 were recruited. In order to validate obtained data and to monitor trends in the incidence of the disease, the data were also gathered for the period from June 1st, 2017 to May 31st, 2018. In season 2016/2017, 51 new cases of pediatric IBD were identified; 19 (37.3%) Crohn’s disease (CD), 28 (54.9%) ulcerative colitis (UC) and 8 (7.8%) IBD unclassified (IBD-U). Male preponderance of all three types of the disease was noticed (CD 52.6%, UC 60.7%, IBD-U 75%). The median age at diagnosis was 14.8 years; 15.3 for CD, 13.9 for UC, and 14.5 years for IBD-U. Female patients were slightly older than males, but without statistically significant difference (p=0.279). With 723,552 children younger than 18 years in Croatia in 2017, the annual incidence of pediatric IBD per 100,000 persons per year was 7.05 (2.62 for CD, 3.87 of UC and 0.55 for IBD-U). The lowest incidence was found in Dubrovnik-Neretva and Split-Dalmatia County (4.50-4.85/100,000 children up to 18 years of age/year), and the highest was found in Meðimurje County (22.80/100,000 children up to 18 years of age/year). Existence of north to south gradient was observed with almost two times higher incidence in northern region compared with southern parts of the country (8.38/100,000 vs. 4.26/100,000). Data from consecutive season (2017/2018) identified 50 new cases of pediatric IBD, with higher proportion of CD (44%) compared to year before. The incidence of pediatric IBD in Croatia is 7.05 per 100,000 persons younger than 18 years per year, with significant decreasing trend in incidences between northern and southern regions of the country.